COMPANY
TEVA UK LIMITED
TEVA UK LIMITED: marketing authorisation holder for Colistin, Ciclosporin, Desmopressin, Icatibant, Octreotide, Teriparatide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Colistin | COLOMYCIN 1 MILLION INTERNATIONAL UNITS. POWDER FOR SOLN FOR INJ, INFUSION OR INHALATION, PL 00289/2255, Authorised Regulator MHRA |
|---|---|
| Colistin | COLOMYCIN 2 MILLION INTERNATIONAL UNITS. POWDER FOR SOLN FOR INJ, INFUSION OR INHALATION, PL 00289/2256, Authorised Regulator MHRA |
| Ciclosporin | VANQUORAL 10 MG CAPSULES, SOFT, PL 00289/1404, Authorised Regulator MHRA |
| Ciclosporin | VANQUORAL 100 MG CAPSULES, SOFT, PL 00289/1407, Authorised Regulator MHRA |
| Ciclosporin | VANQUORAL 25 MG CAPSULES, SOFT, PL 00289/1405, Authorised Regulator MHRA |
| Ciclosporin | VANQUORAL 50 MG CAPSULES, SOFT, PL 00289/1406, Authorised Regulator MHRA |
| Desmopressin | DESMOPRESSIN 120 MICROGRAMS SUBLINGUAL TABLETS, PL 00289/2568, Authorised Regulator MHRA |
| Desmopressin | DESMOPRESSIN 240 MICROGRAMS SUBLINGUAL TABLETS, PL 00289/2569, Authorised Regulator MHRA |
| Icatibant | ICATIBANT TEVA 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 00289/2476, Authorised Regulator MHRA |
| Octreotide | OLATUTON 10 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION, PL 00289/2219, Authorised Regulator MHRA |
| Octreotide | OLATUTON 20 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION, PL 00289/2220, Authorised Regulator MHRA |
| Octreotide | OLATUTON 30 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION, PL 00289/2221, Authorised Regulator MHRA |
| Teriparatide | TERIPARATIDE TEVA 20 MICROGRAMS/80 MICROLITRES SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 00289/2005, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.